[Peripartum cardiomyopathy]
| Autor: | Riccardo Raddino, Ivano Bonadei, Melissa Teli, Federica Chieppa, Giorgio Caretta, Debora Robba, Gregoriana Zanini, Enrico Vizzardi, Livio Dei Cas |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Pulmonary and Respiratory Medicine
Adult Cardiomyopathy Dilated Heart Failure lcsh:R Postpartum Period Pregnancy Complications Cardiovascular peripartum cardiomyopathy lcsh:Medicine Prognosis Ventricular Dysfunction Left Early Diagnosis Echocardiography Pregnancy Risk Factors left ventricular disfunction Humans Female Cardiology and Cardiovascular Medicine |
| Zdroj: | Monaldi Archives for Chest Disease, Vol 70, Iss 1 (2016) |
| ISSN: | 1122-0643 |
| Popis: | Peripartum cardiomyopathy (PPCM) is a rare disorder in which left ventricular dysfunction and symptoms of heart failure occur in the peripartum period in previously healthy women. Incidence of PPCM ranges from 1 in 1300 to 1 in 15,000 pregnancies. The etiology of PPCM is unknown, but viral, autoimmune, and idiopathic causes may contribute. The diagnostic criteria are onset of heart failure in the last month of pregnancy or in the first 5 months postpartum, absence of determinable cause for cardiac failure, and absence of a demonstrable heart disease before the last month of pregnancy. Risk factors for PPCM include advanced maternal age, multiparity, African race, twinning, gestational hypertension, and long-term tocolysis. The clinical presentation of patients with PPCM is similar to that of patients with dilated cardiomyopathy. Echocardiography is central to diagnosis. Early diagnosis and initiation of treatment are essential to optimize pregnancy outcome. Treatment is similar to medical therapy for other forms of dilated cardiomyopathy. About half the patients of PPCM recover without complications. The prognosis is poor in patients with persistent cardiomyopathy. Persistence of disease after 6 months indicates irreversible cardiomyopathy and portends worse survival. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|